Worldwide Prostate Cancer Epidemiology: Differences Between
... With an estimated 1.1 million people affected by prostate cancer in 2012, composing 15% of all new cancer cases worldwide, this condition poses a significant burden of mortality and morbidity on society. Even though the burden of prostate cancer is present worldwide, there are disparities in mortali ...
... With an estimated 1.1 million people affected by prostate cancer in 2012, composing 15% of all new cancer cases worldwide, this condition poses a significant burden of mortality and morbidity on society. Even though the burden of prostate cancer is present worldwide, there are disparities in mortali ...
Intensity Modulated Radiation Therapy
... Percent of normal lung receiving more than 20 Gy (V20%)accounts for more than 35% of the normal lung, defined as the total lung volume minus the planning target volume (PTV) The IMRT plan will reduce the V20% to at least 10% below the V20% that is achieved with the 3D conformal plan (e.g., from 40% ...
... Percent of normal lung receiving more than 20 Gy (V20%)accounts for more than 35% of the normal lung, defined as the total lung volume minus the planning target volume (PTV) The IMRT plan will reduce the V20% to at least 10% below the V20% that is achieved with the 3D conformal plan (e.g., from 40% ...
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant
... abiraterone acetate, enzalutamide, and radium-223. The aim of this study was to assess factors predictive for efficacy of CAB. Methods: We analyzed all patients with mCRPC treated with CAB at our institutions between 2011 and 2016. Data were retrieved retrospectively from the electronical patient ch ...
... abiraterone acetate, enzalutamide, and radium-223. The aim of this study was to assess factors predictive for efficacy of CAB. Methods: We analyzed all patients with mCRPC treated with CAB at our institutions between 2011 and 2016. Data were retrieved retrospectively from the electronical patient ch ...
A Randomised Phase III Trial To Determine The Role Of Fdg – Pet
... (Faslodex) with or without continued Anastrozole (Arimidex) compared with exemestane in post-menopausal women with ER and/or PR +ve locally advanced/metastatic breast cancer following progression on non-steroidal aromatase inhibitors (also available in Altnagelvin) Supremo A Phase III Randomised Tri ...
... (Faslodex) with or without continued Anastrozole (Arimidex) compared with exemestane in post-menopausal women with ER and/or PR +ve locally advanced/metastatic breast cancer following progression on non-steroidal aromatase inhibitors (also available in Altnagelvin) Supremo A Phase III Randomised Tri ...
Document
... RISK FACTORS: 9) Tobacco Use – lung cancer is considered highly preventable because of its relationship to the smoking - large dose and longer use increases risk for developing cancers like cancers in oropharyngeal, esophageal, laryngeal, gastric, pancreatic and bladder - additional research has do ...
... RISK FACTORS: 9) Tobacco Use – lung cancer is considered highly preventable because of its relationship to the smoking - large dose and longer use increases risk for developing cancers like cancers in oropharyngeal, esophageal, laryngeal, gastric, pancreatic and bladder - additional research has do ...
Tilburg University Prostate cancer survivors who would be eligible
... external beam RT as a primary treatment at diagnosis on (a) cancer stage, (b) tumour grade, (c) age at diagnosis (± 2 years), and (d) number of years since diagnosis (± 2 years). Similarly, RT patients were initially diagnosed with a biopsy and subsequently had active treatment after diagnosis. To a ...
... external beam RT as a primary treatment at diagnosis on (a) cancer stage, (b) tumour grade, (c) age at diagnosis (± 2 years), and (d) number of years since diagnosis (± 2 years). Similarly, RT patients were initially diagnosed with a biopsy and subsequently had active treatment after diagnosis. To a ...
MYTH 3: CANCER IS A DEATH SENTENCE
... cancer screening programmes, the reduction in mortality from breast cancer is significant, with for example, Australia’s mammographic screening programme established in 1991, integral to achieving an almost 30% reduction in mortality from breast cancer over the last two decades. • Cervical cancer r ...
... cancer screening programmes, the reduction in mortality from breast cancer is significant, with for example, Australia’s mammographic screening programme established in 1991, integral to achieving an almost 30% reduction in mortality from breast cancer over the last two decades. • Cervical cancer r ...
Genomic Instability of Microsatellite Repeats in
... tation with prostate carcinogenesis. Microsatellite mutations in androgen receptor gene at the CAG trinucleotide repeat could be found in only 1 of 40 (2.5%) patients with prostate cancer (12). Interestingly, this individual later manifested paradoxical agonistic response to hormonal therapy with an ...
... tation with prostate carcinogenesis. Microsatellite mutations in androgen receptor gene at the CAG trinucleotide repeat could be found in only 1 of 40 (2.5%) patients with prostate cancer (12). Interestingly, this individual later manifested paradoxical agonistic response to hormonal therapy with an ...
Conservative Management Outcomes of Localized Prostate Cancer
... 65 years or older when they were diagnosed (1992-2002) with stage T1 or T2 prostate cancer and whose cases were managed without surgery or radiation for 6 months after diagnosis. Living in areas covered by the Surveillance, Epidemiology, and End Results (SEER) program, the men were followed up for a ...
... 65 years or older when they were diagnosed (1992-2002) with stage T1 or T2 prostate cancer and whose cases were managed without surgery or radiation for 6 months after diagnosis. Living in areas covered by the Surveillance, Epidemiology, and End Results (SEER) program, the men were followed up for a ...
FAMILY HISTORY OF BREAST OR OVARIAN CANCER
... allows scientists to look directly at specific genes for cancer-causing mutations. It is possible to test multiple cancer genes at once, according to the cancer risk assessment. It is often necessary to have a blood sample from a family member with cancer in order to participate in genetic testing. ...
... allows scientists to look directly at specific genes for cancer-causing mutations. It is possible to test multiple cancer genes at once, according to the cancer risk assessment. It is often necessary to have a blood sample from a family member with cancer in order to participate in genetic testing. ...
INTERNATIONAL PROSTATE CANCER AWARENESS MONTH
... After a diagnosis with prostate cancer, a man will receive a lot of help from his doctors and hospital staff. However, the need for help doesn’t end at the doctor’s office. Prostate cancer treatments come with the risk of long term side effects such as depression, erectile dysfunction, leaky bowels ...
... After a diagnosis with prostate cancer, a man will receive a lot of help from his doctors and hospital staff. However, the need for help doesn’t end at the doctor’s office. Prostate cancer treatments come with the risk of long term side effects such as depression, erectile dysfunction, leaky bowels ...
The Basics of Cancer
... Based on how far the cancer has progressed & its location in the body it responds differently to treatment. A cancer specialist called an Oncologist will provide the patient with the best treatment plan based on the form of cancer and how aggressive the cancer ...
... Based on how far the cancer has progressed & its location in the body it responds differently to treatment. A cancer specialist called an Oncologist will provide the patient with the best treatment plan based on the form of cancer and how aggressive the cancer ...
The HIF-1α C1772T polymorphism may be associated with
... genotype distribution between patients and controls, although it must be noted that the controls selected in their study were healthy women, who could not have had prostate cancer regardless of genetic predisposition.17 A large case-control cohort also found no association between C1772T genotype an ...
... genotype distribution between patients and controls, although it must be noted that the controls selected in their study were healthy women, who could not have had prostate cancer regardless of genetic predisposition.17 A large case-control cohort also found no association between C1772T genotype an ...
ROLE OF POSITRON EMISSION TOMOGRAPHY WITH
... prostate cancer. Sporadic cases showed increased FDG uptake in aggressive local prostate cancer. FDG uptake is higher in poorly differentiated primary tumour and higher PSA values than in tumours with more localised stage, and lower serum PSA values.17 A recent investigation showed that FDG PET/CT h ...
... prostate cancer. Sporadic cases showed increased FDG uptake in aggressive local prostate cancer. FDG uptake is higher in poorly differentiated primary tumour and higher PSA values than in tumours with more localised stage, and lower serum PSA values.17 A recent investigation showed that FDG PET/CT h ...
Prostate Cancer - National Medical Research Council
... disease at the time of first diagnosis. The prognosis of advanced prostate cancer is poor despite the most aggressive treatment. Cure is impossible for metastatic prostate cancer. The median time to progression and median survival is approximately 18 and 30 months respectively. Such data contrast sh ...
... disease at the time of first diagnosis. The prognosis of advanced prostate cancer is poor despite the most aggressive treatment. Cure is impossible for metastatic prostate cancer. The median time to progression and median survival is approximately 18 and 30 months respectively. Such data contrast sh ...
The Evolving Biology of Castration-Resistant
... molecular analyses of the cells themselves. Perhaps most importantly, the guidelines stress the patient-centric approach to this disease: Not only should overall survival be considered, but so should control of pain and prevention of potentially catastrophic events during disease progression. What C ...
... molecular analyses of the cells themselves. Perhaps most importantly, the guidelines stress the patient-centric approach to this disease: Not only should overall survival be considered, but so should control of pain and prevention of potentially catastrophic events during disease progression. What C ...